Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Millet, R; Goossens, L; Goossens, JF; Chavatte, P; Bertrand-Caumont, K; Houssin, R; Henichart, JP
   Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)(2) deduced from two-dimensional H-1-NMR and conformational energy calculations is related toits affinity for NK1-receptor
   JOURNAL OF PEPTIDE SCIENCE
   
   R. Millet et al., "Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)(2) deduced from two-dimensional H-1-NMR and conformational energy calculations is related toits affinity for NK1-receptor", J PEPT SCI, 7(6), 2001, pp. 323-330
2. Dianzani, C; Lombardi, G; Collino, M; Ferrara, C; Cassone, MC; Fantozzi, R
   Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils
   JOURNAL OF LEUKOCYTE BIOLOGY
   
   C. Dianzani et al., "Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils", J LEUK BIOL, 69(6), 2001, pp. 1013-1018
3. Millet, R; Goossens, L; Bertrand-Caumont, K; Goossens, JF; Houssin, R; Henichart, JP
   A flexible approach to the design of new potent substance P receptor ligands
   JOURNAL OF PHARMACY AND PHARMACOLOGY
   
   R. Millet et al., "A flexible approach to the design of new potent substance P receptor ligands", J PHARM PHA, 53(7), 2001, pp. 929-934
4. Tokita, K; Katsuno, T; Hocart, SJ; Coy, DH; Llinares, M; Martinez, J; Jensen, RT
   Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   K. Tokita et al., "Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor", J BIOL CHEM, 276(39), 2001, pp. 36652-36663
5. Tokita, K; Hocart, SJ; Katsuno, T; Mantey, SA; Coy, DH; Jensen, RT
   Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   K. Tokita et al., "Tyrosine 220 in the 5th transmembrane domain of the neuromedin B receptor is critical for the high selectivity of the peptoid antagonist PD168368", J BIOL CHEM, 276(1), 2001, pp. 495-504
6. Liu, J; Underwood, DJ; Cascieri, MA; Rohrer, SP; Cantin, LD; Chicchi, G; Smith, AB; Hirschmann, R
   Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry
   JOURNAL OF MEDICINAL CHEMISTRY
   
   J. Liu et al., "Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry", J MED CHEM, 43(21), 2000, pp. 3827-3831
7. Huskey, SEW; Luffer-Atlas, D; Dean, BJ; McGowan, EM; Feeney, WP; Chiu, SHL
   Substance P receptor antagonist I: Conversion of phosphoramidate prodrug after i.v. administration to rats and dogs
   DRUG METABOLISM AND DISPOSITION
   
   S.E.W. Huskey et al., "Substance P receptor antagonist I: Conversion of phosphoramidate prodrug after i.v. administration to rats and dogs", DRUG META D, 27(11), 1999, pp. 1367-1373
8. Natsugari, H; Ikeura, Y; Kamo, I; Ishimaru, T; Ishichi, Y; Fujishima, U; Tanaka, T; Kasahara, F; Kawada, M; Doi, T
   Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK1 receptor antagonists: Synthesis, antagonistic activity, and effects on bladder functions
   JOURNAL OF MEDICINAL CHEMISTRY
   
   H. Natsugari et al., "Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK1 receptor antagonists: Synthesis, antagonistic activity, and effects on bladder functions", J MED CHEM, 42(19), 1999, pp. 3982-3993
9. NISHIMURA K; FREDERICK J; KWATRA MM
   HUMAN SUBSTANCE-P RECEPTOR EXPRESSED IN SF9 CELLS COUPLES WITH MULTIPLE ENDOGENOUS G-PROTEINS
   Journal of receptor and signal transduction research
   
   K. Nishimura et al., "HUMAN SUBSTANCE-P RECEPTOR EXPRESSED IN SF9 CELLS COUPLES WITH MULTIPLE ENDOGENOUS G-PROTEINS", Journal of receptor and signal transduction research, 18(1), 1998, pp. 51-65
10. OWENS AP; HARRISON T; MOSELEY JD; SWAIN CJ; SADOWSKI S; CASCIERI MA
    HIGH-AFFINITY PHENYLGLYCINOL-BASED NK1 RECEPTOR ANTAGONISTS
    Bioorganic & medicinal chemistry letters
    
    A.P. Owens et al., "HIGH-AFFINITY PHENYLGLYCINOL-BASED NK1 RECEPTOR ANTAGONISTS", Bioorganic & medicinal chemistry letters, 8(1), 1998, pp. 51-56
11. Schlaeger, EJ; Lundstrom, K
    Effect of temperature on recombinant protein expression in Semliki Forest virus infected mammalian cell lines growing in serum-free suspension cultures
    CYTOTECHNOLOGY
    
    E.J. Schlaeger e K. Lundstrom, "Effect of temperature on recombinant protein expression in Semliki Forest virus infected mammalian cell lines growing in serum-free suspension cultures", CYTOTECHNOL, 28(1-3), 1998, pp. 205-211
12. Lagente, V; Boichot, E; Emonds-Alt, X; Advenier, C
    Value of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, cough and bronchial inflammation.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    
    V. Lagente et al., "Value of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, cough and bronchial inflammation.", REV FR ALLE, 38(10), 1998, pp. 963-971
13. HOLST B; ZOFFMANN S; ELLING CE; HJORTH SA; SCHWARTZ TW
    STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR
    Molecular pharmacology
    
    B. Holst et al., "STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR", Molecular pharmacology, 53(1), 1998, pp. 166-175
14. HALE JJ; MILLS SG; MACCOSS M; FINKE PE; CASCIERI MA; SADOWSKI S; BER E; CHICCHI GG; KURTZ M; METZGER J; EIERMANN G; TSOU NN; TATTERSALL FD; RUPNIAK NMJ; WILLIAMS AR; RYCROFT W; HARGREAVES R; MACINTYRE DE
    STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST
    Journal of medicinal chemistry
    
    J.J. Hale et al., "STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST", Journal of medicinal chemistry, 41(23), 1998, pp. 4607-4614
15. STEVENSON GI; HUSCROFT I; MACLEOD AM; SWAIN CJ; CASCIERI MA; CHICCHI GG; GRAHAM MI; HARRISON T; KELLEHER FJ; KURTZ M; LADDUWAHETTY T; MERCHANT KJ; METZGER JM; MACINTYRE DE; SADOWSKI S; SOHAL B; OWENS AP
    4,4-DISUBSTITUTED PIPERIDINE HIGH-AFFINITY NK1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS AND IN-VIVO ACTIVITY
    Journal of medicinal chemistry
    
    G.I. Stevenson et al., "4,4-DISUBSTITUTED PIPERIDINE HIGH-AFFINITY NK1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS AND IN-VIVO ACTIVITY", Journal of medicinal chemistry, 41(23), 1998, pp. 4623-4635
16. KASHEVEROV IE; UTKIN YN; FRANKE P; TSETLIN VI
    SUBSTANCE-P DERIVATIVES WITH PHOTOACTIVATABLE LABELS IN THE N-TERMINAL PART OF THE MOLECULE
    The journal of peptide research
    
    I.E. Kasheverov et al., "SUBSTANCE-P DERIVATIVES WITH PHOTOACTIVATABLE LABELS IN THE N-TERMINAL PART OF THE MOLECULE", The journal of peptide research, 50(6), 1997, pp. 408-414
17. QUARTARA L; MAGGI CA
    THE TACHYKININ NK1 RECEPTOR - PART I - LIGANDS AND MECHANISMS OF CELLULAR ACTIVATION
    Neuropeptides
    
    L. Quartara e C.A. Maggi, "THE TACHYKININ NK1 RECEPTOR - PART I - LIGANDS AND MECHANISMS OF CELLULAR ACTIVATION", Neuropeptides, 31(6), 1997, pp. 537-563
18. KASHEVEROV IE; UTKIN YN; TSETLIN VI
    ANTAGONISTS OF THE TACHYKININ RECEPTORS
    Bioorganiceskaa himia
    
    I.E. Kasheverov et al., "ANTAGONISTS OF THE TACHYKININ RECEPTORS", Bioorganiceskaa himia, 23(6), 1997, pp. 451-468
19. KRAMER JH; PHILLIPS TM; WEGLICKI WB
    MAGNESIUM-DEFICIENCY-ENHANCED POSTISCHEMIC MYOCARDIAL INJURY IS REDUCED BY SUBSTANCE-P RECEPTOR BLOCKADE
    Journal of Molecular and Cellular Cardiology
    
    J.H. Kramer et al., "MAGNESIUM-DEFICIENCY-ENHANCED POSTISCHEMIC MYOCARDIAL INJURY IS REDUCED BY SUBSTANCE-P RECEPTOR BLOCKADE", Journal of Molecular and Cellular Cardiology, 29(1), 1997, pp. 97-110
20. TURCATTI G; ZOFFMANN S; LOWE JA; DROZDA SE; CHASSAING G; SCHWARTZ TW; CHOLLET A
    CHARACTERIZATION OF NONPEPTIDE ANTAGONIST AND PEPTIDE AGONIST BINDING-SITES OF THE NK1 RECEPTOR WITH FLUORESCENT LIGANDS
    The Journal of biological chemistry
    
    G. Turcatti et al., "CHARACTERIZATION OF NONPEPTIDE ANTAGONIST AND PEPTIDE AGONIST BINDING-SITES OF THE NK1 RECEPTOR WITH FLUORESCENT LIGANDS", The Journal of biological chemistry, 272(34), 1997, pp. 21167-21175
21. LUNDSTROM K; HAWCOCK AB; VARGAS A; WARD P; THOMAS P; NAYLOR A
    EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY
    European journal of pharmacology
    
    K. Lundstrom et al., "EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY", European journal of pharmacology, 337(1), 1997, pp. 73-81
22. CASCIERI MA; BER E; FONG TM; HALE JJ; TANG F; SHIAO LL; MILLS SG; MACCOSS M; SADOWSKI S; TOTA MR; STRADER CD
    CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST
    European journal of pharmacology
    
    M.A. Cascieri et al., "CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST", European journal of pharmacology, 325(2-3), 1997, pp. 253-261
23. IKEURA Y; TANAKA T; KIYOTA Y; MORIMOTO S; OGINO M; ISHIMARU T; KAMO I; DOI T; NATSUGARI H
    POTENT NK1 RECEPTOR ANTAGONISTS - SYNTHESIS AND ANTAGONISTIC ACTIVITYOF VARIOUS HETEROCYCLES WITH AN [3,5-BIS(TRIFLUOROMETHYL)BENZYL]-N-METHYLCARBAMOYL SUBSTITUENT
    Chemical and Pharmaceutical Bulletin
    
    Y. Ikeura et al., "POTENT NK1 RECEPTOR ANTAGONISTS - SYNTHESIS AND ANTAGONISTIC ACTIVITYOF VARIOUS HETEROCYCLES WITH AN [3,5-BIS(TRIFLUOROMETHYL)BENZYL]-N-METHYLCARBAMOYL SUBSTITUENT", Chemical and Pharmaceutical Bulletin, 45(10), 1997, pp. 1642-1652
24. WILSON CJ; HUSAIN SS; STIMSON ER; DANGOTT LJ; MILLER KW; MAGGIO JE
    P-(4-HYDROXYBENZOYL)PHENYLALANINE - A PHOTOREACTIVE AMINO-ACID ANALOGAMENABLE TO RADIOIODINATION FOR ELUCIDATION OF PEPTIDE-PROTEIN INTERACTION APPLICATION TO SUBSTANCE-P RECEPTOR
    Biochemistry
    
    C.J. Wilson et al., "P-(4-HYDROXYBENZOYL)PHENYLALANINE - A PHOTOREACTIVE AMINO-ACID ANALOGAMENABLE TO RADIOIODINATION FOR ELUCIDATION OF PEPTIDE-PROTEIN INTERACTION APPLICATION TO SUBSTANCE-P RECEPTOR", Biochemistry, 36(15), 1997, pp. 4542-4551
25. DENISE DD; SHANDS EFB
    SYSTEMATIC SEARCH STRATEGIES IN CONFORMATIONAL-ANALYSIS
    Drug discovery today
    
    D.D. Denise e E.F.B. Shands, "SYSTEMATIC SEARCH STRATEGIES IN CONFORMATIONAL-ANALYSIS", Drug discovery today, 1(10), 1996, pp. 429-437
26. TEALL M; HARRISON T; MOSELEY JD; OWENS AP; SADOWSKI S; CASCIERI MA
    LINEAR AMIDES AS SUBSTANCE-P ANTAGONISTS
    Bioorganic & medicinal chemistry letters
    
    M. Teall et al., "LINEAR AMIDES AS SUBSTANCE-P ANTAGONISTS", Bioorganic & medicinal chemistry letters, 6(13), 1996, pp. 1585-1588
27. MCLEAN S
    NONPEPTIDE ANTAGONISTS OF THE NK1 TACHYKININ RECEPTOR
    Medicinal research reviews
    
    S. Mclean, "NONPEPTIDE ANTAGONISTS OF THE NK1 TACHYKININ RECEPTOR", Medicinal research reviews, 16(4), 1996, pp. 297-317
28. TATE CG; GRISSHAMMER R
    HETEROLOGOUS EXPRESSION OF G-PROTEIN-COUPLED RECEPTORS
    Trends in biotechnology
    
    C.G. Tate e R. Grisshammer, "HETEROLOGOUS EXPRESSION OF G-PROTEIN-COUPLED RECEPTORS", Trends in biotechnology, 14(11), 1996, pp. 426-430
29. ALLET B; HOCHMANN A; MARTINOU I; BERGER A; MISSOTTEN M; ANTONSSON B; SADOUL R; MARTINOU JC; BERNASCONI L
    DISSECTING PROCESSING AND APOPTOTIC ACTIVITY OF A CYSTEINE PROTEASE BY MUTANT ANALYSIS
    The Journal of cell biology
    
    B. Allet et al., "DISSECTING PROCESSING AND APOPTOTIC ACTIVITY OF A CYSTEINE PROTEASE BY MUTANT ANALYSIS", The Journal of cell biology, 135(2), 1996, pp. 479-486
30. LI HZ; HSU P; SACHAIS BS; KRAUSE JE; LEEMAN SE; BOYD ND
    IDENTIFICATION OF THE SITE IN THE SUBSTANCE-P (NK-1) RECEPTOR FOR MODULATION OF PEPTIDE BINDING BY SULFHYDRYL-REAGENTS
    The Journal of biological chemistry
    
    H.Z. Li et al., "IDENTIFICATION OF THE SITE IN THE SUBSTANCE-P (NK-1) RECEPTOR FOR MODULATION OF PEPTIDE BINDING BY SULFHYDRYL-REAGENTS", The Journal of biological chemistry, 271(4), 1996, pp. 1950-1956
31. CASCIERI MA; FONG TM; STRADER CD
    MOLECULAR CHARACTERIZATION OF A COMMON BINDING-SITE FOR SMALL MOLECULES WITHIN THE TRANSMEMBRANE DOMAIN OF G-PROTEIN COUPLED RECEPTORS
    Journal of pharmacological and toxicological methods
    
    M.A. Cascieri et al., "MOLECULAR CHARACTERIZATION OF A COMMON BINDING-SITE FOR SMALL MOLECULES WITHIN THE TRANSMEMBRANE DOMAIN OF G-PROTEIN COUPLED RECEPTORS", Journal of pharmacological and toxicological methods, 33(4), 1995, pp. 179-185
32. HARRISON T; OWENS AP; WILLIAMS BJ; SWAIN CJ; BAKER R; HUTSON PH; SADOWSKI S; CASCIERI MA
    PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .2. INVESTIGATION OF THE EFFECT OF N-SUBSTITUTION
    Bioorganic & medicinal chemistry letters
    
    T. Harrison et al., "PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .2. INVESTIGATION OF THE EFFECT OF N-SUBSTITUTION", Bioorganic & medicinal chemistry letters, 5(3), 1995, pp. 209-212
33. OWENS AP; WILLIAMS BJ; HARRISON T; SWAIN CJ; BAKER R; SADOWSKI S; CASCIERI MA
    PHENYL-GLYCINOL BASED NK1 RECEPTOR ANTAGONISTS - TOWARDS THE MINIMUM PHARMACOPHORE
    Bioorganic & medicinal chemistry letters
    
    A.P. Owens et al., "PHENYL-GLYCINOL BASED NK1 RECEPTOR ANTAGONISTS - TOWARDS THE MINIMUM PHARMACOPHORE", Bioorganic & medicinal chemistry letters, 5(22), 1995, pp. 2761-2766
34. MAGGI CA
    THE MAMMALIAN TACHYKININ RECEPTORS
    General pharmacology
    
    C.A. Maggi, "THE MAMMALIAN TACHYKININ RECEPTORS", General pharmacology, 26(5), 1995, pp. 911-944
35. ZHANG XL; MAK JCW; BARNES PJ
    CHARACTERIZATION AND AUTORADIOGRAPHIC MAPPING OF [H-3] CP96,345, A NONPEPTIDE SELECTIVE NK1 RECEPTOR ANTAGONIST IN GUINEA-PIG LUNG
    Peptides
    
    X.L. Zhang et al., "CHARACTERIZATION AND AUTORADIOGRAPHIC MAPPING OF [H-3] CP96,345, A NONPEPTIDE SELECTIVE NK1 RECEPTOR ANTAGONIST IN GUINEA-PIG LUNG", Peptides, 16(5), 1995, pp. 867-872
36. STEVENSON GI; MACLEOD AM; HUSCROFT I; CASCIERI MA; SADOWSKI S; BAKER R
    4,4-DISUBSTITUTED PIPERIDINES - A NEW CLASS OF NK1 ANTAGONIST
    Journal of medicinal chemistry
    
    G.I. Stevenson et al., "4,4-DISUBSTITUTED PIPERIDINES - A NEW CLASS OF NK1 ANTAGONIST", Journal of medicinal chemistry, 38(8), 1995, pp. 1264-1266
37. FRANCIS BE; SWAIN C; SABIN V; BURNS HD
    RADIOIODINATED L-703,606 - A POTENT, SELECTIVE ANTAGONIST TO THE HUMAN NK(1) RECEPTOR
    Applied radiation and isotopes
    
    B.E. Francis et al., "RADIOIODINATED L-703,606 - A POTENT, SELECTIVE ANTAGONIST TO THE HUMAN NK(1) RECEPTOR", Applied radiation and isotopes, 45(1), 1994, pp. 97-103
38. HARRISON T; WILLIAMS BJ; SWAIN CJ
    GEM-DISUBSTITUTED AMINO-ETHER BASED SUBSTANCE-P ANTAGONISTS
    Bioorganic & medicinal chemistry letters
    
    T. Harrison et al., "GEM-DISUBSTITUTED AMINO-ETHER BASED SUBSTANCE-P ANTAGONISTS", Bioorganic & medicinal chemistry letters, 4(23), 1994, pp. 2733-2734
39. HARRISON T; WILLIAMS BJ; SWAIN CJ; BALL RG
    PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .1. DETERMINATION OF THE RELATIVE AND ABSOLUTE STEREOCHEMICAL REQUIREMENTS
    Bioorganic & medicinal chemistry letters
    
    T. Harrison et al., "PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .1. DETERMINATION OF THE RELATIVE AND ABSOLUTE STEREOCHEMICAL REQUIREMENTS", Bioorganic & medicinal chemistry letters, 4(21), 1994, pp. 2545-2550
40. FONG TM; STRADER CD
    FUNCTIONAL MAPPING OF THE LIGAND-BINDING SITES OF G-PROTEIN COUPLED RECEPTORS
    Medicinal research reviews
    
    T.M. Fong e C.D. Strader, "FUNCTIONAL MAPPING OF THE LIGAND-BINDING SITES OF G-PROTEIN COUPLED RECEPTORS", Medicinal research reviews, 14(4), 1994, pp. 387-399
41. STRADER CD; FONG TM; TOTA MR; UNDERWOOD D; DIXON RAF
    STRUCTURE AND FUNCTION OF G-PROTEIN-COUPLED RECEPTORS
    Annual review of biochemistry
    
    C.D. Strader et al., "STRUCTURE AND FUNCTION OF G-PROTEIN-COUPLED RECEPTORS", Annual review of biochemistry, 63, 1994, pp. 101-132
42. MEINI S; PATACCHINI R; MAGGI CA
    TACHYKININ NK1 RECEPTOR SUBTYPES IN THE RAT URINARY-BLADDER
    British Journal of Pharmacology
    
    S. Meini et al., "TACHYKININ NK1 RECEPTOR SUBTYPES IN THE RAT URINARY-BLADDER", British Journal of Pharmacology, 111(3), 1994, pp. 739-746
43. LEE JA; BRINKMANN JA; LONGTON ED; PEISHOFF CE; LAGO MA; LEBER JD; COUSINS RD; GAO AM; STADEL JM; KUMAR CS; OHLSTEIN EH; GLEASON JG; ELLIOTT JD
    LYSINE-182 OF ENDOTHELIN-B RECEPTOR MODULATES AGONIST SELECTIVITY ANDANTAGONIST AFFINITY - EVIDENCE FOR THE OVER-LAP OF PEPTIDE AND NONPEPTIDE LIGAND-BINDING SITES
    Biochemistry
    
    J.A. Lee et al., "LYSINE-182 OF ENDOTHELIN-B RECEPTOR MODULATES AGONIST SELECTIVITY ANDANTAGONIST AFFINITY - EVIDENCE FOR THE OVER-LAP OF PEPTIDE AND NONPEPTIDE LIGAND-BINDING SITES", Biochemistry, 33(48), 1994, pp. 14543-14549
44. SWAIN CJ; SEWARD EM; SABIN V; OWEN S; BAKER R; CASCIERI MA; SADOWSKI S; STRADER C; BALL RG
    QUINUCLIDINE BASED NK-1 ANTAGONISTS .2. DETERMINATION OF THE ABSOLUTESTEREOCHEMICAL REQUIREMENTS
    Bioorganic & medicinal chemistry letters
    
    C.J. Swain et al., "QUINUCLIDINE BASED NK-1 ANTAGONISTS .2. DETERMINATION OF THE ABSOLUTESTEREOCHEMICAL REQUIREMENTS", Bioorganic & medicinal chemistry letters, 3(8), 1993, pp. 1703-1706
45. FONG TM; HUANG RRC; YU H; STRADER CD
    MAPPING THE LIGAND-BINDING SITE OF THE NK-1 RECEPTOR
    Regulatory peptides
    
    T.M. Fong et al., "MAPPING THE LIGAND-BINDING SITE OF THE NK-1 RECEPTOR", Regulatory peptides, 46(1-2), 1993, pp. 43-48